Home/Filings/4/0001209191-23-016688
4//SEC Filing

Dethlefs Sven 4

Accession 0001209191-23-016688

CIK 0000818686other

Filed

Mar 6, 7:00 PM ET

Accepted

Mar 7, 4:04 PM ET

Size

17.9 KB

Accession

0001209191-23-016688

Insider Transaction Report

Form 4
Period: 2023-03-03
Dethlefs Sven
EVP Global Marketing&Portfolio
Transactions
  • Exercise/Conversion

    Ordinary Shares

    2023-03-04+13,931179,312 total
  • Exercise/Conversion

    Ordinary Shares

    2023-03-04+38,538217,850 total
  • Exercise/Conversion

    Ordinary Shares

    2023-03-05+24,952242,802 total
  • Award

    Restricted Share Units

    2023-03-03+99,60199,601 total
    Ordinary Shares (99,601 underlying)
  • Exercise/Conversion

    Restricted Share Units

    2023-03-0413,9310 total
    Ordinary Shares (13,931 underlying)
  • Exercise/Conversion

    Restricted Share Units

    2023-03-0438,538115,617 total
    Ordinary Shares (38,538 underlying)
  • Exercise/Conversion

    Restricted Share Units

    2023-03-0524,95249,905 total
    Ordinary Shares (24,952 underlying)
Footnotes (6)
  • [F1]The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.
  • [F2]Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share.
  • [F3]Restricted share units were granted on March 3, 2023, with 24,900 vesting on each of March 3, 2024, March 3, 2025 and March 3, 2026, and 24,901 vesting on March 3, 2027.
  • [F4]Restricted share units were granted on March 4, 2019, with 13,930 vested on each of March 4, 2021 and March 4, 2022, and 13,931 vested on March 4, 2023.
  • [F5]Restricted share units were granted on March 4, 2022, with 33,538 vested on March 4, 2023, 33,538 vesting on each of March 4, 2024 and March 4, 2025, and 38,541 vesting on March 4, 2026.
  • [F6]Restricted share units were granted on March 5, 2021, with 24,952 vested on each of March 5, 2022, March 5, 2023 and March 5, 2024, and 24,953 vesting on March 5, 2025.

Issuer

TEVA PHARMACEUTICAL INDUSTRIES LTD

CIK 0000818686

Entity typeother

Related Parties

1
  • filerCIK 0001726010

Filing Metadata

Form type
4
Filed
Mar 6, 7:00 PM ET
Accepted
Mar 7, 4:04 PM ET
Size
17.9 KB